Taysha Gene Therapies Inc (TSHA)

Oct 16, 2025

Why Taysha Gene Therapies Inc. stock is favored by top institutionsJuly 2025 Trends & Community Verified Trade Signals - newser.com

Oct 16, 2025

Oct 16, 2025

Taysha regains full rights to Rett syndrome gene therapy program By Investing.com - Investing.com South Africa

Oct 16, 2025

Oct 16, 2025

Taysha (TSHA) Reclaims Full Rights to Key Rett Syndrome Program - GuruFocus

Oct 16, 2025

Oct 16, 2025

Taysha Gene Therapies Regains Full Rights to TSHA-102 Program - TradingView

Oct 16, 2025

Oct 16, 2025

Why Taysha Gene Therapies Inc. is moving todayJuly 2025 Big Picture & AI Based Buy/Sell Signal Reports - newser.com

Oct 16, 2025

Oct 16, 2025

Taysha Gene Therapies Regains Full Rights to Lead TSHA-102 - GlobeNewswire

Oct 16, 2025

Oct 16, 2025

Taysha Regains Full Rights to TSHA-102; 100% Part A Response | TSHA Stock News - Stock Titan

Oct 16, 2025

Oct 15, 2025

Taysha Gene Therapies stock hits 52-week high at $5.41 By Investing.com - Investing.com Nigeria

Oct 15, 2025

Oct 15, 2025

Earnings visualization tools for Taysha Gene Therapies Inc.Quarterly Trade Summary & Advanced Swing Trade Entry Alerts - newser.com

Oct 15, 2025

Oct 15, 2025

Tick level data insight on Taysha Gene Therapies Inc. volatilityJuly 2025 Sector Moves & Safe Entry Point Alerts - newser.com

Oct 15, 2025

Oct 15, 2025

Taysha Gene Therapies stock hits 52-week high at $5.41 - Investing.com

Oct 15, 2025

Oct 13, 2025

Taysha Gene Therapies stock rating reiterated at Market Outperform by Citizens - Investing.com Canada

Oct 13, 2025

Oct 10, 2025

Has Taysha Gene Therapies Inc. formed a bullish divergenceJuly 2025 Decliners & Low Drawdown Investment Strategies - newser.com

Oct 10, 2025

Oct 10, 2025

Collegium Pharmaceutical, Inc. (COLL): A Bull Case Theory - MSN

Oct 10, 2025

Oct 10, 2025

What MACD and RSI say about Taysha Gene Therapies Inc.2025 Volume Leaders & Smart Allocation Stock Tips - newser.com

Oct 10, 2025

Oct 10, 2025

Can Taysha Gene Therapies Inc. stock hit record highs again2025 Volatility Report & Verified Entry Point Signals - newser.com

Oct 10, 2025

Oct 10, 2025

Is Taysha Gene Therapies Inc. trending in predictive chart modelsPortfolio Return Report & Consistent Income Trade Ideas - newser.com

Oct 10, 2025

Oct 09, 2025

Weiss Ratings Reiterates Sell (D-) Rating for Taysha Gene Therapies (NASDAQ:TSHA) - MarketBeat

Oct 09, 2025

Oct 09, 2025

Taysha Gene Therapies Hits Day High with 7.2% Surge in Stock Price - Markets Mojo

Oct 09, 2025

Oct 09, 2025

Taysha Gene Therapies (TSHA) Reveals Enhanced Trial Results for Rett Syndrome - GuruFocus

Oct 09, 2025

Oct 09, 2025

Taysha Gene Therapies Presents New Supplemental Data Analysis from Part A of the REVEAL Phase 1/2 Trials for TSHA-102 in Rett Syndrome at the 54th CNS Annual Meeting - The Manila Times

Oct 09, 2025

Oct 09, 2025

Taysha Gene Therapies Presents New Supplemental Data - GlobeNewswire

Oct 09, 2025

Oct 09, 2025

Taysha's TSHA-102 Shows 100% Response in Phase 1/2 Rett Trial | TSHA Stock News - Stock Titan

Oct 09, 2025

Oct 09, 2025

Will Taysha Gene Therapies Inc. stock continue dividend increasesMarket Sentiment Summary & Technical Entry and Exit Tips - newser.com

Oct 09, 2025

Oct 09, 2025

Analyzing net buyer seller activity in Taysha Gene Therapies Inc.Weekly Trade Analysis & Growth Oriented Trading Recommendations - newser.com

Oct 09, 2025

Oct 09, 2025

Visual analytics tools that track Taysha Gene Therapies Inc. performanceEarnings Beat & Daily Technical Stock Forecast Reports - newser.com

Oct 09, 2025

Oct 07, 2025

Taysha Gene Therapies Hits Day Low of $4.40 Amid Price Pressure - Markets Mojo

Oct 07, 2025

Oct 07, 2025

Taysha Gene Therapies, Inc. Sees Revision in Stock Evaluation Amid Strong Market Performance - Markets Mojo

Oct 07, 2025

Oct 07, 2025

Taysha soars on FDA breakthrough therapy status for lead asset - MSN

Oct 07, 2025

Oct 06, 2025

Taysha Gene Therapies (NASDAQ:TSHA) Trading Down 4.9%Time to Sell? - MarketBeat

Oct 06, 2025

Oct 06, 2025

Taysha Gene Therapies Hits New 52-Week High at $5.40 - Markets Mojo

Oct 06, 2025

Oct 06, 2025

Taysha Gene Therapies: Breakthrough Rett Program With BLA Acceleration Potential (TSHA) - Seeking Alpha

Oct 06, 2025

Oct 06, 2025

Will Taysha Gene Therapies Inc. stock maintain growth story2025 Trading Volume Trends & Fast Moving Market Watchlists - newser.com

Oct 06, 2025

Oct 05, 2025

How to interpret RSI for Taysha Gene Therapies Inc. stockWeekly Trade Analysis & Low Volatility Stock Recommendations - newser.com

Oct 05, 2025

Oct 05, 2025

Taysha Snags FDA Breakthrough Therapy Designation for Rett Syndrome Gene Therapy TSHA-102 - CGTLive®

Oct 05, 2025

Oct 04, 2025

How Recent Developments Are Rewriting the Story for Taysha Gene Therapies - Yahoo Finance

Oct 04, 2025

Oct 04, 2025

Taysha Gene Therapies (TSHA) Gets a Buy from Canaccord Genuity - The Globe and Mail

Oct 04, 2025

Oct 04, 2025

Taysha Gene Therapies Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4) - GlobeNewswire

Oct 04, 2025

Oct 04, 2025

Needham & Company LLC Issues Positive Forecast for Taysha Gene Therapies (NASDAQ:TSHA) Stock Price - Defense World

Oct 04, 2025

Oct 04, 2025

Best Small Cap Stocks To Add to Your Watchlist – October 2nd - Defense World

Oct 04, 2025